Abstract:BACKGROUND:Improving poorly soluble drugs into druggability was a major problem faced by pharmaceutists. Nanosuspension can improve the druggability of insoluble drugs by improving the solubility, chemical stability and reducing the use of additives, which provided a new approach for the development and application of the insoluble drugs formulation. Paclitaxel (PTX) is a well-known BCS class IV drug with poor solubility and permeability. Also, many studies have proved that paclitaxel is a substrate of the membrane-bound drug efflux pump P-glycoprotein (P-gp), therefore it often shows limited efficacy against the resistant tumors and oral absorption or uptake. OBJECTIVE:To manufacture an enhanced-penetration PTX nanosuspension (PTX-Nanos), and evaluate the physicochemical property, pharmacokinetics and tissue distribution in vivo and cytotoxic effect in vitro. METHODS:PTX-Nanos were prepared by microprecipitation-high pressure homogenization, with a good biocompatibility amphiphilic block copolymer poly(L-phenylalanine)-b-poly(L-aspartic acid) (PPA-PAA) as stabilizer. RESULTS:The PTX-Nanos had a sustained-dissolution manner and could effectively reduce plasma peak concentration and extend plasma circulating time as compared to PTX injection, markedly passively targeting the MPS-related organs, such as liver and spleen. This unique property might enhance treatment of cancer in these tissues and reduce the side effects in other normal tissues. Moreover, the hybrid stabilizers could enhance penetration of PTX in PTX-Nanos to multidrug resistance cells. CONCLUSION:To sum up, our results showed that the optimal formula could improve the solubility of PTX and the stability of the product. The PTX-Nanos developed in this research would be a promising delivery platform in cancer treatment.

Advances in strategies of improving solubility and permeability of taxanes

Probing the new strategy for the oral formulations of taxanes: changing the method with the situation

Novel formulations of taxanes: a review. Old wine in a new bottle?

Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension.

Solubilization Methods for Paclitaxel and Docetaxel: An Overview

Nano-Porous Silica Aerogels As Promising Biomaterials for Oral Drug Delivery of Paclitaxel.

Enhanced Oral Bioavailability of Docetaxel by Lecithin Nanoparticles: Preparation, in Vitro, and in Vivo Evaluation

A Study on Improving Bioavailability of Paclitaxel through different Novel Drug Delivery Approaches

Enhanced Water Solubility and Oral Bioavailability of Paclitaxel Crystal Powders through an Innovative Antisolvent Precipitation Process: Antisolvent Crystallization Using Ionic Liquids as Solvent

Recent Progress of Paclitaxel Delivery Systems: Covalent and Noncovalent Approaches

Engineering of dendritic mesoporous silica nanoparticles for efficient delivery of water-insoluble paclitaxel in cancer therapy

Facile Preparation of Paclitaxel Nano-Suspensions to Treat Lung Cancer

Enabling oral novel Taxanes-based Chemotherapy with Lipophilic prodrug Self-nanoemulsifying drug delivery system

Novel Oral Administrated Paclitaxel Micelles with Enhanced Bioavailability and Antitumor Efficacy for Resistant Breast Cancer.

Strategies in Taxol development. A review.

Strategy For Increasing Drug Solubility And Efficacy Through Covalent Attachment To Polyvalent Dna - Nanoparticle Conjugates

Progress in the Study of Taxanes Against Multi-Drug Resistant Tumor

Current advances of anticancer drugs based on solubilization technology

Multi-functional Chitosan Polymeric Micelles As Oral Paclitaxel Delivery Systems for Enhanced Bioavailability and Anti-Tumor Efficacy.

Preclinical evaluation of albumin-bound docetaxel nanoparticles as potential anti-cancer products

Studies on Preparation and in Vitro and in Vivo Evaluation of Docetaxel Solid Dispersion